Until recently, human clinical trials with neuroprotective agents have failed, with the probable exception of deep barbiturate-induced coma.
Donedavno, klinička ispitivanja na ljudima s neuroprotektivnim tvarima nisu uspjela, s vjerojatnom iznimkom duboke barbituratne kome.